Company receives multimillion dollar grant to focus on post-stroke recovery; Proven technology in 700 patients granted Breakthrough Device designation from the FDA EFFINGHAM, Ill.--(BUSINESS ...
A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.
Racism, discrimination, and social determinants of health have contributed to clear disparities in health and health outcomes, particularly in central nervous system (CNS) disorders. Recognizing the ...
Guanosine, a purine nucleoside, has emerged as a potent modulator within the central nervous system (CNS), contributing to neuroprotection through a diverse array of mechanisms. It plays a critical ...
FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. (AP Photo/Ted Shaffrey, File) (Ted Shaffrey, Copyright 2024 The Associated ...
Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and spinal cord and is characterized by a variety of neurologic symptoms at ...
The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...
This color-coded graphic shows different populations of cells in the mouse brain, each one targeted by one of the genetic tools developed by scientists at the Allen Institute and other institutions.
Praxis Precision Medicines develops therapies for central nervous system disorders, targeting unmet needs in neurology and psychiatry.
Foods rich in magnesium, omega-3s, probiotics, antioxidants, and more can help your nervous system function properly, ...